Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 7/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 3/20 | 0.31 |
| ▸ | CTSD | P07339 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.30 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
| ▸ | SRPK2 | P78362 | 1/20 | 0.30 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17704032 | 0.92 | ABCC9 (0.34) | ABCC9PGR | |
| SCHEMBL17703994 | 0.92 | PGR (0.35) | ABCC9PGRCTSDBACE1PIK3CD | |
| SCHEMBL17704013 | 0.90 | CYP11B2 (0.36) | ABCC9BACE1PIK3CD | |
| SCHEMBL17703990 | 0.89 | ABCC9 (0.33) | ABCC9TNKS2PGRPIK3CDPIK3CA | |
| SCHEMBL17703995 | 0.89 | CYP11B2 (0.41) | ABCC9CTSDBACE1PIK3CDPIK3CA | |
| SCHEMBL17704058 | 0.89 | PIK3CD (0.39) | ABCC9PGRPIK3CDPIK3CA | |
| SCHEMBL17704055 | 0.88 | KIF11 (0.35) | ABCC9PGRPIK3CDPIK3CA | |
| SCHEMBL17704068 | 0.87 | ABCC9 (0.35) | ABCC9TNKS2PGRCTSDBACE1 | |
| SCHEMBL17704059 | 0.87 | TNKS2 (0.32) | ABCC9TNKS2 | |
| SCHEMBL17704011 | 0.86 | ABCC9 (0.34) | ABCC9PGRCTSDBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9722187-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-20160118599-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118599-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, AOX1, CYP1A1 | ABCC9 2989/4885TNKS2 3678/4885PGR 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.